{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:31:53Z","timestamp":1740173513531,"version":"3.37.3"},"reference-count":57,"publisher":"Endocrinology Research Centre","issue":"6","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>In recent years, there has been a significant increase in the prevalence of autoimmune endocrinopathies, which are known to affect various levels of the endocrine system, including the pituitary gland. Hypophysitis is a general term used to describe any form of sellar and suprasellar inflammation that leads to structural changes in the hypothalamic-pituitary region and manifests itself in varying degrees of hormonal deficiency of the anterior and posterior pituitary glands. To date, there is a\u00a0primary form of hypophysitis, which occurs as a result of an autoimmune lesion directly to the pituitary gland, and a\u00a0secondary form of hypophysitis, which occurs as a result of the presence of a systemic autoimmune disease. Regardless of the etiology, patients with hypophysitis show various signs and symptoms caused by an inflammatory process in the pituitary gland, which can lead to the development of hypopituitarism, compression of the sellar and parasellar structures. MRI is currently the best non-invasive diagnostic tool for diagnosing hypopituitarism, however, the diagnosis can be made with certainty only by histological examination of the pituitary tissue, which requires an invasive approach, which greatly reduces the feasibility of this procedure. In this article, we present a patient with MRI showing signs of hypophysitis in the absence of clear clinical symptoms.<\/jats:p>","DOI":"10.14341\/probl13311","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:16:18Z","timestamp":1706638578000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":0,"title":["Differential diagnosis and tactics of managing a patient with primary hypophysitis on the example of a clinical case"],"prefix":"10.14341","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2094-8731","authenticated-orcid":true,"given":"N. N.","family":"Katamadze","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7695-6182","authenticated-orcid":true,"given":"A. A.","family":"Tskaeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-466X","authenticated-orcid":true,"given":"E. A.","family":"Pigarova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-4619","authenticated-orcid":true,"given":"L. K.","family":"Dzeranova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-9454","authenticated-orcid":true,"given":"N. V.","family":"Tarbaeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5458","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Kluczy\u0144ski \u0141, Gilis-Januszewska A, Rogozi\u0144ski D, et al. Hypophysitis \u2014 new insights into diagnosis and treatment. Endokrynol Pol. 2019;70(3):260-269. doi: https:\/\/doi.org\/10.5603\/EP.a2019.0015","DOI":"10.5603\/EP.a2019.0015"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Vorontsov AV, Babaeva DM, Vladimirova VP, et al. Clinical and radiological diagnosis of hypophysitis: a review of literature and own data. Problems of Endocrinology. 2022;68(2):16-33. (In Russ.). doi: https:\/\/doi.org\/10.14341\/probl12777","DOI":"10.14341\/probl12777"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Fukuoka H. Hypophysitis. Endocrinol Metab Clin N Am. 2015;(44):143-149.","DOI":"10.1016\/j.ecl.2014.10.011"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kleinschmidt\u2010DeMasters BK, Lopes MBS. Update on hypophysitis and TTF\u20101 expressing sellar region masses. Brain Pathol. 2013;23(5):495-514. doi: https:\/\/doi.org\/10.1111\/bpa.12068","DOI":"10.1111\/bpa.12068"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Scanarini M, D\u2019Avella D, Rotilio A, et al. Giant-cell granulomatous hypophysitis: a distinct clinicopathological entity. J Neurosurg. 1989;71(5):681-686. doi: https:\/\/doi.org\/10.3171\/jns.1989.71.5.0681","DOI":"10.3171\/jns.1989.71.5.0681"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Vasile M, Marsot-Dupuch K, Kujas M, et al. Idiopathic granulomatous hypophysitis: clinical and imaging features. Neuroradiology. 1997;39(1):7-11. doi: https:\/\/doi.org\/10.1007\/s002340050357","DOI":"10.1007\/s002340050357"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Deodhare SS, Bilbao JM, Kovacs K, et al. Xanthomatous hypophysitis: A novel entity of obscure etiology. Endocr Pathol. 1999;10(3):237-241. doi: https:\/\/doi.org\/10.1007\/BF02738885","DOI":"10.1007\/BF02738885"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Cosman F, Post KD, Holub DA, Wardlaw SL. Lymphocytic hypophysitis. report of 3 new cases and review of the literature. Medicine (Baltimore). 1989;68(4):240. doi: https:\/\/doi.org\/10.1097\/00005792-198907000-00006","DOI":"10.1097\/00005792-198907000-00006"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Hassoun P, Anayssi E, Salti I. A case of granulomatous hypophysitis with hypopituitarism and minimal pituitary enlargement. J Neurol Neurosurg Psychiatry. 1985;48(9):949-951. doi: https:\/\/doi.org\/10.1136\/jnnp.48.9.949","DOI":"10.1136\/jnnp.48.9.949"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Fehn M, Sommer C, L\u00fcdecke DK, et al. Lymphocytic hypophysitis: Light and electron microscopic findings and correlation to clinical appearance. Endocr Pathol. 1998;9(1):71-78. doi: https:\/\/doi.org\/10.1007\/BF02739954","DOI":"10.1007\/BF02739954"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lyadova MA, Lyadov VK. Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review. J Mod Oncol. 2021;23(2):319-326. (In Russ.). doi: https:\/\/doi.org\/10.26442\/18151434.2021.2.200502","DOI":"10.26442\/18151434.2021.2.200502"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Caturegli P, Newschaffer C, Olivi A, et al. Autoimmune hypophysitis. Endocr Rev. 2005;26(5):599-614. doi: https:\/\/doi.org\/10.1210\/er.2004-0011","DOI":"10.1210\/er.2004-0011"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Leporati P, Landek-Salgado MA, Lupi I, et al. IgG4-related hypophysitis: A new addition to the hypophysitis spectrum. J Clin Endocrinol Metab. 2011;96(7):1971-1980. doi: https:\/\/doi.org\/10.1210\/jc.2010-2970","DOI":"10.1210\/jc.2010-2970"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001;8(4):287-305. doi: https:\/\/doi.org\/10.1677\/erc.0.0080287","DOI":"10.1677\/erc.0.0080287"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Minniti G, Jaffrain-Rea M-L, Osti M, et al. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev. 2007;30(3):167-176. doi: https:\/\/doi.org\/10.1007\/s10143-007-0072-x","DOI":"10.1007\/s10143-007-0072-x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4\u2010related disease. Arthritis Rheumatol. 2015;67(7):1688-1699. doi: https:\/\/doi.org\/10.1002\/art.39132","DOI":"10.1002\/art.39132"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: A cross-sectional study in the province of Li\u00e8ge, Belgium. J Clin Endocrinol Metab. 2006;91(12):4769-4775. doi: https:\/\/doi.org\/10.1210\/jc.2006-1668","DOI":"10.1210\/jc.2006-1668"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas. Cancer. 2004;101(3):613-619. doi: https:\/\/doi.org\/10.1002\/cncr.20412","DOI":"10.1002\/cncr.20412"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ferrante E, Ferraroni M, Castrignano\u0300 T, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006;155(6):823-829. doi: https:\/\/doi.org\/10.1530\/eje.1.02298","DOI":"10.1530\/eje.1.02298"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Dekkers OM, Pereira AM, Roelfsema F, et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91(5):1796-1801. doi: https:\/\/doi.org\/10.1210\/jc.2005-2552","DOI":"10.1210\/jc.2005-2552"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA. Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101371. doi: https:\/\/doi.org\/10.1016\/j.beem.2019.101371","DOI":"10.1016\/j.beem.2019.101371"},{"key":"ref22","unstructured":"Naran J, Can AS. Lymphocytic Hypophysitis 2020. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Gorbova NY, Vladimirova VP, Rozhinskaya LY, Belaya ZY. Hypophysitis and reversible hypopituitarism developed after COVID-19 infection \u2014 a clinical case report. Problems of Endocrinology. 2022;68(3):50-56. (In Russ.)]. doi: https:\/\/doi.org\/10.14341\/probl12896","DOI":"10.14341\/probl12896"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Caputo C, Bazargan A, McKelvie PA, et al. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy. Pituitary. 2014;17(3):251-256. doi: https:\/\/doi.org\/10.1007\/s11102-013-0498-9","DOI":"10.1007\/s11102-013-0498-9"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Gorbova NY, Vladimirova VP, Rozhinskaya LY, Belaya ZY. Hypophysitis and reversible hypopituitarism developed after COVID-19 infection \u2014 a clinical case report. Problems of Endocrinology. 2022;68(3):50-56. (In Russ.). doi: https:\/\/doi.org\/10.14341\/probl12896","DOI":"10.14341\/probl12896"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Yuen KCJ, Moloney KJ, Mercado JU, et al. A case series of atypical features of patients with biopsy-proven isolated IgG4related hypophysitis and normal serum IgG4 levels. Pituitary. 2018;21(3):238-246. doi: https:\/\/doi.org\/10.1007\/s11102-017-0852-4","DOI":"10.1007\/s11102-017-0852-4"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Chu JN, Goglin S, Patzek S, Brondfield S. Granulomatosis with polyangiitis presenting as hypophysitis. Am J Med. 2019;132(1):e21-e22. doi: https:\/\/doi.org\/10.1016\/j.amjmed.2018.09.004","DOI":"10.1016\/j.amjmed.2018.09.004"},{"key":"ref28","unstructured":"Tao, T. et al. (2018) Lymphocytic hypophysitis associated with Behcet\u2019s disease: a case report and review of the literature. Neuro Endocrinol Lett. 2018;39(1):43-48."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Freeman HJ, Maguire J. Sellar inflammatory mass with inflammatory bowel disease. Can J Gastroenterol. 2010;24(1):58-60. doi: https:\/\/doi.org\/10.1155\/2010\/650692","DOI":"10.1155\/2010\/650692"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Spinner CD, Noe S, Schwerdtfeger C, et al. Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIVinfected patient: a case report. BMC Infect Dis. 2013;13(1):481. doi: https:\/\/doi.org\/10.1186\/1471-2334-13-481","DOI":"10.1186\/1471-2334-13-481"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Ogul H, Pirimoglu B, Gungor A, et al. Brucella hypophysitis. Acta Neurol Belg. 2015;115(3):433-434. doi: https:\/\/doi.org\/10.1007\/s13760-014-0373-0","DOI":"10.1007\/s13760-014-0373-0"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Angelousi A, Chatzellis E, Kaltsas G. New molecular, biological, and immunological agents inducing hypophysitis. Neuroendocrinology. 2018;106(1):89-100. doi: https:\/\/doi.org\/10.1159\/000480086","DOI":"10.1159\/000480086"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Tebben PJ, Atkinson JLD, Scheithauer BW, Erickson D. Granulomatous adenohypophysitis after interferon and ribavirin therapy. Endocr Pract. 2007;13(2):169-175. doi: https:\/\/doi.org\/10.4158\/EP.13.2.169","DOI":"10.4158\/EP.13.2.169"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ridruejo E, Christensen AF, Mando OG. Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin. Eur J Gastroenterol Hepatol. 2006;18(6):693-694. doi: https:\/\/doi.org\/10.1097\/00042737-200606000-00019","DOI":"10.1097\/00042737-200606000-00019"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Caturegli P. Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab. 2007;92(6):2038-2040. doi: https:\/\/doi.org\/10.1210\/jc.2007-0808","DOI":"10.1210\/jc.2007-0808"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Hayashi Y, Oishi M, Daisuke K, et al. Pure lymphocytic infundibuloneurohypophysitis caused by the rupture of rathke\u2019s cleft cyst; report of 2 cases and review of the literature. Turk Neurosurg. 2015;25(2):332-336. doi: https:\/\/doi.org\/10.5137\/1019-5149.JTN.9776-13.0","DOI":"10.5137\/1019-5149.JTN.9776-13.0"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Nishikawa T, Takahashi JA, Shimatsu A, Hashimoto N. Hypophysitis caused by Rathke\u2019s cleft cyst-case report. Neurol Med Chir (Tokyo). 2007;47(3):136-139. doi: https:\/\/doi.org\/10.2176\/nmc.47.136","DOI":"10.2176\/nmc.47.136"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"McLaughlin N, Lavigne F, Kilty S, et al. Hypophysitis secondary to a ruptured rathke cleft cyst. Can J Neurol Sci. 2010;37(3):402-405. doi: https:\/\/doi.org\/10.1017\/S0317167100010349","DOI":"10.1017\/S0317167100010349"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Yang C, Wu H, Bao X, Wang R. Lymphocytic hypophysitis secondary to ruptured rathke cleft cyst: case report and literature review. World Neurosurg. 2018;(114):172-177. doi: https:\/\/doi.org\/10.1016\/j.wneu.2018.03.086","DOI":"10.1016\/j.wneu.2018.03.086"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Schittenhelm J, Beschorner R, Psaras T, et al. Rathke\u2019s cleft cyst rupture as potential initial event of a secondary perifocal lymphocytic hypophysitis: proposal of an unusual pathogenetic event and review of the literature. Neurosurg Rev. 2008;31(2):157-163. doi: https:\/\/doi.org\/10.1007\/s10143-008-0120-1","DOI":"10.1007\/s10143-008-0120-1"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Khare S, Jagtap VS, Budyal SR, et al. Primary (autoimmune) hypophysitis: a single centre experience. Pituitary. 2015;18(1):16-22. doi: https:\/\/doi.org\/10.1007\/s11102-013-0550-9","DOI":"10.1007\/s11102-013-0550-9"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Chiloiro S, Tartaglione T, Angelini F, et al. An overview of diagnosis of primary autoimmune hypophysitis in a prospective singlecenter experience. Neuroendocrinology. 2017;104(3):280-290. doi: https:\/\/doi.org\/10.1159\/000446544","DOI":"10.1159\/000446544"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Tartaglione T, Chiloiro S, Laino ME, et al. Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis. Pituitary. 2018;21(4):414-424. doi: https:\/\/doi.org\/10.1007\/s11102-018-0892-4","DOI":"10.1007\/s11102-018-0892-4"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Honegger J, Schlaffer S, Menzel C, et al. Diagnosis of primary hypophysitis in Germany. J Clin Endocrinol Metab. 2015;100(10):3841-3849. doi: https:\/\/doi.org\/10.1210\/jc.2015-2152","DOI":"10.1210\/jc.2015-2152"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Byun DJ, Wolchok JD, Rosenberg LM, Girotra M. Cancer immunotherapy \u2014 immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol. 2017;13(4):195-207. doi: https:\/\/doi.org\/10.1038\/nrendo.2016.205","DOI":"10.1038\/nrendo.2016.205"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Faje A. Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary. 2016;19(1):82-92. doi: https:\/\/doi.org\/10.1007\/s11102-015-0671-4","DOI":"10.1007\/s11102-015-0671-4"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Bernreuther C, Illies C, Flitsch J, et al. IgG4\u2010related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis. Brain Pathol. 2017;27(6):839-845. doi: https:\/\/doi.org\/10.1111\/bpa.12459","DOI":"10.1111\/bpa.12459"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Rivera JA. Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary. 2006;9(1):35-45. doi: https:\/\/doi.org\/10.1007\/s11102-006-6598-z","DOI":"10.1007\/s11102-006-6598-z"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Bottazzo GF, Florin-Christensen A, Pouplard A, Doniach D. Autoantibodies to prolactin-secreting cells of human pituitary. Lancet. 1975;306(7925):97-101. doi: https:\/\/doi.org\/10.1016\/S0140-6736(75)90004-5","DOI":"10.1016\/S0140-6736(75)90004-5"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Faje AT, Sullivan R, Lawrence D, et al. Ipilimumab-induced hypophysitis: A detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab. 2014;99(11):4078-4085. doi: https:\/\/doi.org\/10.1210\/jc.2014-2306","DOI":"10.1210\/jc.2014-2306"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Bhansali A, Velayutham P, Radotra BD, Pathak A. Idiopathic granulomatous hypophysitis presenting as nonfunctioning pituitary adenoma: description of six cases and review of literature. Br J Neurosurg. 2004;18(5):489-494. doi: https:\/\/doi.org\/10.1080\/02688690400012376","DOI":"10.1080\/02688690400012376"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. Am J Neuroradiol. 2009;30(9):1766-1772. doi: https:\/\/doi.org\/10.3174\/ajnr.A1714","DOI":"10.3174\/ajnr.A1714"},{"key":"ref53","unstructured":"Seidenwurm DJ. Neuroendocrine imaging. AJNR Am J Neuroradiol. 2008;29(3):613-615."},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Waytz J, Jan R. IgG-4\u2013related hypophysitis treated with rituximab. JCR J Clin Rheumatol. 2021;27(8S):S340-S341. doi: https:\/\/doi.org\/10.1097\/RHU.0000000000001624","DOI":"10.1097\/RHU.0000000000001624"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Boharoon H, Tomlinson J, Limback-Stanic C, et al. A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab. J Endocr Soc. 2020;4(6):bvaa048. doi: https:\/\/doi.org\/10.1210\/jendso\/bvaa048","DOI":"10.1210\/jendso\/bvaa048"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Bellastella G, Maiorino MI, Bizzarro A, et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary. 2016;19(6):625-642. doi: https:\/\/doi.org\/10.1007\/s11102-016-0736-z","DOI":"10.1007\/s11102-016-0736-z"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Lupi I, Cosottini M, Caturegli P, et al. Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis. Eur J Endocrinol. 2017;177(2):127-135. doi: https:\/\/doi.org\/10.1530\/EJE-17-0123","DOI":"10.1530\/EJE-17-0123"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/13311\/10589","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:17:43Z","timestamp":1706638663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/13311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,1,25]]}},"URL":"https:\/\/doi.org\/10.14341\/probl13311","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"type":"electronic","value":"2308-1430"},{"type":"print","value":"0375-9660"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}